Getting Mounjaro on an NHS Scotland Prescription

Tirzepatide (Mounjaro) has not received a Scottish Medicines Consortium recommendation for NHS weight management, so routine NHS Scotland access is not currently available.
Scotland's NHS criteria for GLP-1 weight-loss medicines differ from NHS England's phased rollout — thresholds and eligible conditions are set separately.
A private prescription for Mounjaro on prescription in Scotland requires clinical assessment by a registered prescriber; eligibility is based on BMI and weight-related health conditions per the licensed criteria.
NICE TA1026 (December 2024) recommends tirzepatide for England; its reach does not automatically extend to NHS Scotland, where the SMC runs a separate process.

Mounjaro is not routinely available on NHS Scotland prescription for weight management at present. Scotland sets its own access criteria, and tirzepatide has not yet been recommended by the Scottish Medicines Consortium for weight loss on the NHS — meaning most people pursuing it in Scotland do so through a private prescription route. Here is what the current guidance says, and what your realistic options are.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

NHS Scotland, Private Routes, and What the Trial Evidence Means for Scottish Patients

What NICE TA1026 does (and doesn't) mean for Scotland

In December 2024, NICE published Technology Appraisal 1026, recommending tirzepatide for weight management in adults with a BMI of 35 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes. Lower BMI thresholds apply for South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds under that guidance. It is an important milestone, but it does not apply in Scotland.

Health technology decisions in Scotland run through the Scottish Medicines Consortium, not NICE. The SMC assesses medicines independently and advises NHS Scotland boards on which treatments to fund. Until the SMC completes its own review and issues a positive recommendation, NHS Scotland health boards have no uniform funding route for tirzepatide in weight management. The criteria that govern Scottish NHS access to GLP-1 weight-loss medicines differ from those in England, and checking the NHS inform Scotland resources is the most reliable way to stay current on any changes.

That said, the clinical trial data underpinning TA1026 covers everyone, not just English patients. SURMOUNT-1, published in the New England Journal of Medicine, reported an average body-weight reduction of around 20 to 21 percent over 72 weeks at the 15mg maintenance dose. Those figures informed NICE's recommendation and will feed into any SMC review, the evidence itself is not in dispute, only the commissioning decision.

How people in Scotland are accessing Mounjaro now

Because NHS Scotland has not yet made tirzepatide routinely available for weight management, the practical route for most Scottish patients today is a private Mounjaro prescription. A private prescription requires exactly the same clinical assessment as any prescription: a registered prescriber reviews your medical history, BMI, weight-related conditions, current medicines, and any contraindications. There are no shortcuts. What changes is the funding, you pay privately rather than through the NHS.

Private clinics and online pharmacies registered with the GPhC can issue and dispense private prescriptions across the UK, including in Scotland. If you want to understand how a prescription for Mounjaro is issued in practice, the process is the same whether you live in Edinburgh, Glasgow, Inverness or anywhere else: consultation, prescriber assessment, approval if clinically suitable, and dispensing through a licensed pharmacy.

One thing worth knowing for everyday life: Mounjaro is stored in the fridge, so wherever you pick it up, you will want a consistent spot at home, the fridge door works well for many people, provided temperatures stay between 2°C and 8°C. Always check the Patient Information Leaflet for the exact room-temperature window before travelling.

What the private prescription route actually involves

Private access to Mounjaro in Scotland follows the licensed eligibility criteria set out in the medicine's Summary of Product Characteristics. Adults with a BMI of 30 or above qualify on BMI alone; those with a BMI between 27 and 29.9 may qualify if they have at least one weight-related condition. A prescriber weighs up the full picture, not just a single number.

For a sense of what the private market looks like on cost, our overview of Mounjaro pricing in the UK covers what to expect and what headline prices often leave out. The short version: a legitimate private prescription includes clinical assessment; prices that appear very low without any consultation attached are a warning sign, not a bargain. The MHRA has warned repeatedly about counterfeit weight-loss pens sold online without clinical oversight, and Scottish patients are just as exposed to that risk as anyone else.

Treatment starts at 2.5mg, a tolerability dose whose job is to ease your system into the medicine before the prescriber titrates upward. The full titration schedule is in the SmPC and the Patient Information Leaflet; dosing decisions rest with your prescriber, not a guide online.

What Scottish patients should do now

If you are in Scotland and want to know whether tirzepatide is right for you, the NHS inform Scotland pages on diabetes and weight-loss medication are a reasonable starting point for understanding the devolved landscape. NHS Inform Scotland is updated as national guidance changes, so it is worth bookmarking.

For people who do not want to wait for an NHS Scotland decision (or who do not meet the criteria even if access widens) a private prescription is available now through a GPhC-registered pharmacy. You can verify any pharmacy's registration at the GPhC register before handing over any personal or payment details. A valid registration number and a prescriber in the loop are the two non-negotiables.

At nume, our prescribers review every consultation personally (the same day) and if treatment is clinically appropriate, it is dispatched the same day for free next-working-day delivery across the UK, including Scotland. If you want to explore whether private treatment is right for you, learn more about Mounjaro or check your eligibility with a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions